CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Patron Exim Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Patron Exim Ltd
Corporate Road
Prahlad Nagar,, 411, Safal Prelude,
AHMEDABAD, 380015  India Ticker: 543798543798
Business Summary
Patron Exim Limited is an India-based company, which is primarily engaged in pharmaceutical business, including trading of pharma products and commission agent in pharma products. It is involved in the trading and distribution of a range of pharmaceutical raw material which is known as active pharmaceutical ingredients (APIs), industrial, excipient and solvents. The Company’s product portfolio comprises of around 150 AIPs, excipient, pharma chemical and intermediates. It is also in the trading of variety of chemicals, such as, petrochemicals, dyes and pigment chemicals, paints, and specialty chemical, agro chemicals, oil and refinery chemicals, foam and adhesive, plywood and laminates chemical. The range of Chemicals also includes food industry and water treatment chemicals, resins and plastics chemicals, polymers, and additives etc. The geographical territory in which the Company operates is Ahmedabad and the surrounding area of Gujarat.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20233/31/2023-----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5169 Chemicals and allied products, not elsewhere classified
5172 Petroleum and petroleum products wholesalers, except bulk station

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer HardikkumarPatel 9/7/2022 9/7/2022
Managing Director, Executive Director Narendrakumar G.Patel 66 9/14/2022 8/24/2022
Non-Executive Non-Independent Director Bhumishth N.Patel 40 9/14/2022 9/14/2022
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 23,180,000 (As of 3/31/2023)
Stock Exchange: BOM


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024